Magnetic resonance and computed tomography imaging in multiple myeloma.
F E Lecouvet, B C Vande Berg, J Malghem...
https://pubmed.ncbi.nlm.nih.gov/11371335/Actively Recruiting
Led by Cliniques universitaires Saint-Luc- Université Catholique de Louvain · Updated on 2026-04-24
45
Participants Needed
1
Research Sites
N/A
Total Duration
This research evaluates new MRI techniques called pseudo-CT sequences, designed to improve the detection of bone lesions in people with multiple myeloma bone disease. These sequences aim to combine bone marrow assessment and bone damage detection in a single, non-irradiating imaging exam. Advances include using deep learning to enhance image quality and correct artifacts, which may increase diagnostic accuracy compared to current imaging methods. The study uses whole-body MRI with optimized pseudo-CT sequences like Zero Echo Time ZTE and Lava Flex Low Flip Angle LF, which better visualize mineral bone similar to CT scans but without radiation exposure. Participants receive standard care follow-up with PETCT and whole-body MRI incorporating these new sequences. This approach seeks to compare the diagnostic performance of these imaging protocols during the study. Participants will undergo imaging assessments for about one year, including both traditional PETCT and the new whole-body MRI with pseudo-CT sequences. Researchers will evaluate how well these imaging methods detect bone lesions by comparing sensitivity and predictive accuracy. The study monitors all imaging results to understand the diagnostic value of these new MRI techniques for multiple myeloma bone disease.
CONDITIONS
"Pseudo-scanner" MRI Sequences for the Detection of Bone Lesions in Multiple Myeloma
F
Frédéric Lecouvet
P
Perrine Triqueneaux
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Lead Sponsor
General Electric
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 1 day
Participants undergo whole-body MRI including ZTE sequences to detect bone lesions in multiple myeloma alongside standard PET/CT scans.
1 visit (in-person)
Duration - Up to 1 year
Participants are monitored for up to 1 year to evaluate the diagnostic performance and compare imaging protocols.
Follow-up visits according to standard care
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Have more questions? Get in touch with our team for quick support
F E Lecouvet, B C Vande Berg, J Malghem...
https://pubmed.ncbi.nlm.nih.gov/11371335/Frédéric E Lecouvet, Dimitar Boyadzhiev, Laurence Collette...
https://pubmed.ncbi.nlm.nih.gov/31844960/Frederic E Lecouvet, Deniz Zan, Darius Lepot...
https://pubmed.ncbi.nlm.nih.gov/39377681/Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Lead Sponsor
General Electric
Collaborating Sponsor